{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:22:35Z","timestamp":1794050555246,"version":"4.8.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["19EIA34660321"],"award-info":[{"award-number":["19EIA34660321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R35HL150766"],"award-info":[{"award-number":["R35HL150766"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS123469"],"award-info":[{"award-number":["R21NS123469"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["8264963"],"award-info":[{"award-number":["8264963"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["856332"],"award-info":[{"award-number":["856332"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["874025"],"award-info":[{"award-number":["874025"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.healun.2022.12.012","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:22:11Z","timestamp":1671589331000},"page":"544-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Vascular pathobiology of pulmonary hypertension"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-0878","authenticated-orcid":false,"given":"Eunate","family":"Gallardo-Vara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-580X","authenticated-orcid":false,"given":"Aglaia","family":"Ntokou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui M.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-5942","authenticated-orcid":false,"given":"Daniel G.","family":"Jovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-9729","authenticated-orcid":false,"given":"Fatima Z.","family":"Saddouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9842-3751","authenticated-orcid":false,"given":"Daniel M.","family":"Greif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.12.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.12.012_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/biomedicines9010057","article-title":"Endothelial dysfunction in pulmonary hypertension: cause or consequence?","volume":"9","author":"Kurakula","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.healun.2022.12.012_bib0003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0004","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1096\/fj.04-3261fje","article-title":"Voelkel NF: Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells","volume":"19","author":"Sakao","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.healun.2022.12.012_bib0005","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.healun.2022.12.012_bib0007","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4161\/cc.8.20.9618","article-title":"HIF-1alpha versus HIF-2alpha in endothelial cells and vascular functions: is there a master in angiogenesis regulation?","volume":"8","author":"Skuli","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.healun.2022.12.012_bib0008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.953","article-title":"Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis","volume":"195","author":"Tuder","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0009","first-page":"L256","article-title":"Endothelial HIF-2\u03b1 contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2353\/ajpath.2010.090832","article-title":"Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells","volume":"176","author":"Fijalkowska","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.healun.2022.12.012_bib0012","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1 alpha is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.healun.2022.12.012_bib0013","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1073\/pnas.140087397","article-title":"The transcription factor EPAS-1\/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling","volume":"97","author":"Peng","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2022.12.012_bib0014","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"Tian","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.healun.2022.12.012_bib0015","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm721","article-title":"Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice","volume":"8","author":"Compernolle","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1266","article-title":"Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-\/- mice","volume":"35","author":"Scortegagna","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.healun.2022.12.012_bib0017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/386403a0","article-title":"Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT","volume":"386","author":"Maltepe","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.healun.2022.12.012_bib0018","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI15496","article-title":"Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia","volume":"111","author":"Brusselmans","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.12.012_bib0019","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1172\/JCI5912","article-title":"Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha","volume":"103","author":"Yu","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.12.012_bib0020","first-page":"L256","article-title":"Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0021","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.celrep.2018.03.043","article-title":"Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension","volume":"23","author":"Sheikh","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.healun.2022.12.012_bib0022","doi-asserted-by":"crossref","first-page":"L209","DOI":"10.1152\/ajplung.00185.2005","article-title":"Vascular endothelial growth factor in the lung","volume":"290","author":"Voelkel","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.healun.2022.12.012_bib0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/dvdy.10095","article-title":"Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung","volume":"224","author":"Greenberg","year":"2002","journal-title":"Dev Dyn"},{"key":"10.1016\/j.healun.2022.12.012_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2466-9-18","article-title":"Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis","volume":"9","author":"Papaioannou","year":"2009","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0026","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1440-1827.2000.01068.x","article-title":"Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension","volume":"50","author":"Hirose","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.healun.2022.12.012_bib0027","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.healun.2022.12.012_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1165\/ajrcmb.23.6.4106","article-title":"Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats","volume":"23","author":"Partovian","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-020-0811-5","article-title":"Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension","volume":"115","author":"Winter","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0030","article-title":"Bayesian inference associates Rare KDR variants with specific phenotypes in pulmonary arterial hypertension","volume":"14","author":"Swietlik","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0031","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/rcmb.2014-0045TR","article-title":"The role of vascular endothelial growth factor in pulmonary arterial hypertension. the angiogenesis paradox","volume":"51","author":"Voelkel","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0032","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/ajrccm.158.3.9802066","article-title":"Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension","volume":"158","author":"Kaneko","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2017.06.012","article-title":"The nitric oxide pathway in pulmonary vascular disease","volume":"120","author":"Klinger","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0034","doi-asserted-by":"crossref","first-page":"C824","DOI":"10.1152\/ajpcell.00592.2005","article-title":"Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA","volume":"292","author":"Zuckerbraun","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1067\/mva.2000.105006","article-title":"Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42\/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate","volume":"31","author":"Kibbe","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.healun.2022.12.012_bib0036","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1172\/JCI3862","article-title":"The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia","volume":"103","author":"Fagan","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.12.012_bib0037","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.1073\/pnas.182225899","article-title":"Kadowitz PJ: adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice","volume":"99","author":"Champion","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2022.12.012_bib0038","first-page":"58","article-title":"Critical role of caveolin-1 loss\/dysfunction in pulmonary hypertension","volume":"9","author":"Mathew","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.healun.2022.12.012_bib0039","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI33338","article-title":"Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration","volume":"119","author":"Zhao","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.12.012_bib0040","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000141576.39579.23","article-title":"Disruption of endothelial-cell caveolin-1alpha\/raft scaffolding during development of monocrotaline-induced pulmonary hypertension","volume":"110","author":"Mathew","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0041","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1378\/chest.129.3.696","article-title":"Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension","volume":"129","author":"Achcar","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.12.012_bib0042","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.healun.2022.12.012_bib0043","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/16000617.0067-2015","article-title":"Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension","volume":"24","author":"Lang","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.healun.2022.12.012_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.107.134221","article-title":"Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis","volume":"326","author":"Cathcart","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.healun.2022.12.012_bib0045","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.107.716241","article-title":"Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells","volume":"117","author":"Fredenburgh","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0046","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.lfs.2012.07.033","article-title":"Endothelin receptor antagonists for the treatment of pulmonary artery hypertension","volume":"91","author":"Rubin","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.healun.2022.12.012_bib0047","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm.165.3.2104059","article-title":"ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells","volume":"165","author":"Davie","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0048","first-page":"PA5043","article-title":"Functional study of polymorphisms in the promoter region of the endothelin-1 gene in Pullmonary Artery Hypertension","volume":"54","author":"Villar","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.12.012_bib0049","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.phrs.2011.03.003","article-title":"The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension","volume":"63","author":"Shao","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0051","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1152\/jappl.1995.79.6.2122","article-title":"Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats","volume":"79","author":"Chen","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0052","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00005344-199706000-00003","article-title":"The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats","volume":"29","author":"Chen","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.healun.2022.12.012_bib0053","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.201501-0196OC","article-title":"Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension","volume":"192","author":"Benza","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0054","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.12.012_bib0055","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/ATVBAHA.119.313357","article-title":"Endothelial BMPR2 loss drives a proliferative response to BMP (bone morphogenetic protein) 9 via prolonged canonical signaling","volume":"40","author":"Theilmann","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0056","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0057","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0058","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/ATVBAHA.121.313788","article-title":"Endothelial-Mesenchymal Transition in Cardiovascular Disease","volume":"41","author":"Alvandi","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0059","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCULATIONAHA.113.003734","article-title":"Endothelial fate mapping in mice with pulmonary hypertension","volume":"129","author":"Qiao","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0061","first-page":"151","article-title":"Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression","volume":"100","author":"Meyrick","year":"1980","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0062","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.celrep.2014.01.042","article-title":"Recapitulation of developing artery muscularization in pulmonary hypertension","volume":"6","author":"Sheikh","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.healun.2022.12.012_bib0063","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9712","article-title":"Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension","volume":"7","author":"Sheikh","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0064","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","article-title":"Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension","volume":"178","author":"Perros","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1183\/09031936.00174908","article-title":"Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension","volume":"34","author":"Selimovic","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.12.012_bib0066","doi-asserted-by":"crossref","first-page":"L826","DOI":"10.1152\/ajplung.00199.2002","article-title":"Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus","volume":"284","author":"Balasubramaniam","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0067","doi-asserted-by":"crossref","first-page":"e139067","DOI":"10.1172\/jci.insight.139067","article-title":"Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension","volume":"6","author":"Ntokou","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2022.12.012_bib0068","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13073-021-00891-1","article-title":"Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH","volume":"13","author":"Zhu","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0069","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/ATVBAHA.114.304864","article-title":"Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension","volume":"35","author":"Ten Freyhaus","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0070","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nm.2021","article-title":"Notch3 signaling promotes the development of pulmonary arterial hypertension","volume":"15","author":"Li","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0071","doi-asserted-by":"crossref","first-page":"e142338","DOI":"10.1172\/JCI142338","article-title":"JAGGED1\/NOTCH3 activation promotes aortic hypermuscularization and stenosis in elastin deficiency","volume":"132","author":"Dave","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2022.12.012_bib0072","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mgg3.58","article-title":"Mutations of NOTCH3 in childhood pulmonary arterial hypertension","volume":"2","author":"Chida","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0073","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.28.5.915","article-title":"The Terminal Portion of the Pulmonary Arterial Tree in People Native to High Altitudes","volume":"28","author":"Arias-Stella","year":"1963","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0074","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thx.28.6.701","article-title":"Pathology of chronic mountain sickness","volume":"28","author":"Arias-Stella","year":"1973","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2022.12.012_bib0075","first-page":"542","article-title":"New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension","volume":"57","author":"Hislop","year":"1976","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0076","doi-asserted-by":"crossref","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","article-title":"Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure","volume":"297","author":"Stenmark","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0077","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1alpha","volume":"189","author":"Ball","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0078","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcp.28953","article-title":"HIF1alpha-induced upregulation of KLF4 promotes migration of human vascular smooth muscle cells under hypoxia","volume":"235","author":"Shan","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0079","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00109-017-1619-0","article-title":"FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension","volume":"96","author":"Bourgeois","year":"2018","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.healun.2022.12.012_bib0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1165\/rcmb.2011-0128OC","article-title":"Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1","volume":"46","author":"Raghavan","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0081","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0082","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nm.3695","article-title":"Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension","volume":"20","author":"Savai","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0083","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2016.07.192","article-title":"Elevated levels of plasma transforming growth factor-beta1 in idiopathic and heritable pulmonary arterial hypertension","volume":"222","author":"Yan","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0084","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2353\/ajpath.2009.080565","volume":"174","author":"Thomas","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0085","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1074\/jbc.M706797200","article-title":"Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells","volume":"283","author":"Yu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2022.12.012_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.03.011","article-title":"PPARgamma Links BMP2 and TGFbeta1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism","volume":"25","author":"Calvier","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.healun.2022.12.012_bib0087","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1183\/09059180.00011104","article-title":"High-altitude pulmonary hypertension","volume":"18","author":"Xu","year":"2009","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.healun.2022.12.012_bib0088","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/hrt.33.5.647","article-title":"Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level","volume":"33","author":"Sime","year":"1971","journal-title":"Br Heart J"},{"key":"10.1016\/j.healun.2022.12.012_bib0089","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005602","article-title":"Reoxygenation reverses hypoxic pulmonary arterial remodeling by inducing smooth muscle cell apoptosis via reactive oxygen species-mediated mitochondrial dysfunction","volume":"6","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.12.012_bib0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yexmp.2012.03.010","article-title":"Reversal of pulmonary vascular remodeling in pulmonary hypertensive rats","volume":"93","author":"Sluiter","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0091","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCULATIONAHA.112.133413","article-title":"Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension","volume":"127","author":"Dromparis","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0092","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-030-11093-2_3","article-title":"Pericytes in the Lung","volume":"1122","author":"Hung","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0093","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/j.2040-4603.2021.tb00178.x","article-title":"Lung pericytes in pulmonary vascular physiology and pathophysiology","volume":"11","author":"Yuan","year":"2021","journal-title":"Compr Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0094","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.119.313715","article-title":"Lineage tracing reveals the dynamic contribution of pericytes to the blood vessel remodeling in pulmonary hypertension","volume":"40","author":"Bordenave","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0095","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCULATIONAHA.113.007469","article-title":"Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension","volume":"129","author":"Ricard","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0096","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.118.037642","article-title":"Loss of endothelium-derived wnt5a is associated with reduced pericyte recruitment and small vessel loss in pulmonary arterial hypertension","volume":"139","author":"Yuan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0097","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/j.2040-4603.2011.tb00317.x","article-title":"The adventitia: essential role in pulmonary vascular remodeling","volume":"1","author":"Stenmark","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0098","first-page":"389","article-title":"Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension","volume":"146","author":"Chazova","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0099","doi-asserted-by":"crossref","first-page":"L976","DOI":"10.1152\/ajplung.00382.2001","article-title":"Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia","volume":"282","author":"Das","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0100","doi-asserted-by":"crossref","first-page":"15631","DOI":"10.1074\/jbc.M010690200","article-title":"Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases","volume":"276","author":"Das","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2022.12.012_bib0101","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00136.2018","article-title":"Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension","volume":"315","author":"Thenappan","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0102","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.3603030","article-title":"Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension","volume":"237","author":"Mecham","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.healun.2022.12.012_bib0103","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.RES.66.4.968","article-title":"Collagen and elastin metabolism in hypertensive pulmonary arteries of rats","volume":"66","author":"Poiani","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0104","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1152\/japplphysiol.90563.2008","article-title":"Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure","volume":"105","author":"Shifren","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0105","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCRESAHA.119.315348","article-title":"Heterogeneous cellular contributions to elastic laminae formation in arterial wall development","volume":"125","author":"Lin","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0106","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/ajrccm\/146.1.213","article-title":"Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease","volume":"146","author":"Todorovich-Hunter","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.healun.2022.12.012_bib0107","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.chest.2021.06.028","article-title":"Severe pulmonary arterial hypertension is characterized by increased neutrophil elastase and relative elafin deficiency","volume":"160","author":"Sweatt","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.12.012_bib0108","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/hc0402.102866","article-title":"Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension","volume":"105","author":"Zaidi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.12.012_bib0109","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000510048","article-title":"In situ evidence of collagen V and interleukin-6\/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension","volume":"87","author":"Batah","year":"2020","journal-title":"Pathobiology"},{"key":"10.1016\/j.healun.2022.12.012_bib0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.celrep.2015.09.049","article-title":"Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP\/TAZ-miR-130\/301 Circuit","volume":"13","author":"Bertero","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.healun.2022.12.012_bib0111","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201409-1742OC","article-title":"Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension","volume":"191","author":"Damico","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.12.012_bib0112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1165\/rcmb.2019-0056OC","article-title":"Functional impact of human genetic variants of COL18A1\/endostatin on pulmonary endothelium","volume":"62","author":"Goyanes","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0113","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00725-2021","article-title":"COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study","volume":"8","author":"Simpson","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0114","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/cells9112338","article-title":"Perivascular inflammation in pulmonary arterial hypertension","volume":"9","author":"Hu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.healun.2022.12.012_bib0115","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2022.12.012_bib0116","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.4049\/jimmunol.1900239","article-title":"Nonclassical monocytes sense hypoxia, regulate pulmonary vascular remodeling, and promote pulmonary hypertension","volume":"204","author":"Yu","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2022.12.012_bib0117","doi-asserted-by":"crossref","first-page":"763","DOI":"10.33549\/physiolres.933187","article-title":"Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1","volume":"65","author":"Zaloudikova","year":"2016","journal-title":"Physiol Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0119","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2022.12.012_bib0120","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1152\/ajplung.2001.280.1.L39","article-title":"Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension","volume":"280","author":"Fujita","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0121","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/1756-185X.12304","article-title":"Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension","volume":"19","author":"Zhang","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.healun.2022.12.012_bib0122","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.thromres.2010.06.020","article-title":"Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study","volume":"126","author":"Can","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0123","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.hlc.2014.11.025","article-title":"Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension","volume":"24","author":"Zheng","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.healun.2022.12.012_bib0124","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/ATVBAHA.114.304404","article-title":"Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension","volume":"34","author":"Yaoita","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2022.12.012_bib0125","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/j.thromres.2010.08.020","article-title":"Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension","volume":"126","author":"Tournier","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.thromres.2021.07.015","article-title":"The dynamics of thrombin formation in patients with pulmonary arterial hypertension","volume":"208","author":"Melnichnikova","year":"2021","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.healun.2022.12.012_bib0127","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/diagnostics10100758","article-title":"Coagulation profiles of pulmonary arterial hypertension patients, assessed by non-conventional hemostatic tests and markers of platelet activation and endothelial dysfunction","volume":"10","author":"Vrigkou","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.healun.2022.12.012_bib0128","doi-asserted-by":"crossref","first-page":"L739","DOI":"10.1152\/ajplung.00500.2020","article-title":"Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension","volume":"320","author":"Aulak","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0129","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00389.2019","article-title":"Platelet glycolytic metabolism correlates with hemodynamic severity in pulmonary arterial hypertension","volume":"318","author":"McDowell","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2022.12.012_bib0130","doi-asserted-by":"crossref","first-page":"e91415","DOI":"10.1172\/jci.insight.91415","article-title":"Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity","volume":"2","author":"Nguyen","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.healun.2022.12.012_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110149","article-title":"Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine\/LOX-1 signaling-impelled intercellular communication","volume":"87","author":"Ge","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.healun.2022.12.012_bib0132","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCRESAHA.114.303662","article-title":"Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension","volume":"114","author":"Bauer","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2022.12.012_bib0133","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herv\u00e9","year":"1995","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.healun.2022.12.012_bib0134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0002-9343(90)90111-P","article-title":"Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin","volume":"89","author":"Herve","year":"1990","journal-title":"Am J Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:50:26Z","timestamp":1760950226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822022562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":134,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1053249822022562"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.12.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular pathobiology of pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}